What’s past is prologue. These words from William Shakespeare are on my mind as I conclude nearly 20 years of working in the nation’s dynamic health-care sector – both with the biotech company Celgene and as a board member for one of the country’s most forward-looking hospital and integrated clinical care systems located right here in New Jersey.
As I reflect on what I’ve learned, I’m amazed by the progress achieved during this period. From the dramatic breakthroughs in treating HIV to significant advances for patients with cardiovascular disease to finding a cure for hepatitis C, American health-care innovation has transformed grave illnesses into manageable conditions and found cures for serious diseases.
